1
|
Wang N, Xue T, Zheng W, Shao Z, Liu Z, Dai F, Xie Q, Sang J, Ye X. Safety and efficacy of percutaneous biopsy and microwave ablation in patients with pulmonary nodules on antithrombotic therapy: A study with rivaroxaban bridging. Thorac Cancer 2024. [PMID: 39155057 DOI: 10.1111/1759-7714.15425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Revised: 07/27/2024] [Accepted: 07/30/2024] [Indexed: 08/20/2024] Open
Abstract
BACKGROUND To evaluate the safety and efficacy of percutaneous biopsy and microwave ablation (B + MWA) in patients with pulmonary nodules (PNs) who are receiving antithrombotic therapy by rivaroxaban as bridging therapy. METHODS The study comprised 187 patients with PNs who underwent 187 B + MWA sessions from January 1, 2020, to December 31, 2021. The enrolled patients were divided into two groups: Group A, who received antithrombotic therapy five days before the procedure and received rivaroxaban as a bridging drug during hospitalization, and group B, who had no antithrombotic treatment. Information about the technical success rate, positive biopsy rate, complete ablative rate, and major complications were collected and analyzed. RESULTS Group A comprised 53 patients and group B comprised 134 patients. The technical success rate was 100% in both groups. The positive biopsy rates were 88.68% and 91.04%, respectively (p = 0.6211, X2 = 0.2443). In groups A and B, the complete ablative rates at 6, 12, and 24 months were 100.0% versus 99.25%, 96.23% versus 96.27%, and 88.68% versus 89.55%, respectively. There were no significant differences in bleeding and thrombotic complications between the two groups. No grade 5 complications occurred. CONCLUSIONS It is generally considered safe and effective that patients who are on antithrombotic therapy by rivaroxaban as bridging to undergo B + MWA for treating PNs.
Collapse
Affiliation(s)
- Nan Wang
- Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, People's Republic of China
| | - Tianyu Xue
- Department of Clinical Medicine, Jining Medical University, Jining, People's Republic of China
| | - Wenwen Zheng
- Department of Technical, Beijing Rheinhealthcare Technology Co., Limited liability company, Beijing, People's Republic of China
| | - Zhongying Shao
- Department of Hepatology, Tai'an Hospital of Traditional Chinese Medicine, Tai'an, People's Republic of China
| | - Zhuang Liu
- Department of Technical, Beijing Rheinhealthcare Technology Co., Limited liability company, Beijing, People's Republic of China
| | - Faliang Dai
- Department of Minimally invasive, Caoxian People's Hospital, Heze, People's Republic of China
| | - Qi Xie
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, People's Republic of China
| | - Jing Sang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, People's Republic of China
| | - Xin Ye
- Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, People's Republic of China
| |
Collapse
|
2
|
Liu B, Ye X, Fan W, Zhi X, Ma H, Wang J, Wang P, Wang Z, Wang H, Wang X, Niu L, Fang Y, Gu S, Lu Q, Tian H, Zhu Y, Qiao G, Zhong L, Wei Z, Zhuang Y, Liu H, Liu L, Liu L, Chi J, Sun Q, Sun J, Sun X, Yang N, Mu J, Li Y, Li C, Li C, Li X, Li K, Yang P, Yang X, Yang F, Yang W, Xiao Y, Zhang C, Zhang K, Zhang L, Zhang C, Zhang L, Zhang Y, Chen S, Chen J, Chen K, Chen W, Chen L, Chen H, Fan J, Lin Z, Lin D, Xian L, Meng Z, Zhao X, Hu J, Hu H, Liu C, Liu C, Zhong W, Yu X, Jiang G, Jiao W, Yao W, Yao F, Gu C, Xu D, Xu Q, Ling D, Tang Z, Huang Y, Huang G, Peng Z, Dong L, Jiang L, Jiang J, Cheng Z, Cheng Z, Zeng Q, Jin Y, Lei G, Liao Y, Tan Q, Zhai B, Li H. Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition). J Cancer Res Ther 2024; 20:1109-1123. [PMID: 39206972 DOI: 10.4103/jcrt.jcrt_563_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2024] [Accepted: 07/11/2024] [Indexed: 09/04/2024]
Abstract
ABSTRACT This expert consensus reviews current literature and provides clinical practice guidelines for the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main contents of this review include the following: ① follow-up strategies, ② differential diagnosis, ③ diagnosis and staging, ④ treatment methods, and ⑤ post-treatment follow-up.
Collapse
Affiliation(s)
- Baodong Liu
- Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Xin Ye
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Weijun Fan
- Department of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Xiuyi Zhi
- Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Haitao Ma
- Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
| | - Jun Wang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Peng Wang
- Minimally Invasive Cancer Treatment Center, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Zhongmin Wang
- Department of Interventional Radiology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Hongwu Wang
- Center for Respiratory Diseases, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Xiaoping Wang
- Endoscopy Center, Shandong Public Health Clinical Center, Jinan, China
| | - Lizhi Niu
- Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou, China
| | - Yong Fang
- Department of Medical Oncology, Sir Run Run Shaw Hospital Affiliated to the Zhejiang University School of Medicine, Hangzhou, China
| | - Shanzhi Gu
- Department of Intervention, Hunan Cancer Hospital, Changsha, China
| | - Qiang Lu
- Department of Thoracic Surgery, Tangdu Hospital, The Air Force Medical University, Xi'an, China
| | - Hui Tian
- Department of Thoracic Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Yulong Zhu
- Department of Respiratory Medicine, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, China
| | - Guibin Qiao
- Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangzhou, China
| | - Lou Zhong
- Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China
| | - Zhigang Wei
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Yiping Zhuang
- Department for Interventional Treatment, Jiangsu Cancer Hospital, Nanjing, China
| | - Hongxu Liu
- Department of Thoracic Surgery, Liaoning Cancer Hospital and Institute, Shenyang, China
| | - Lingxiao Liu
- Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Lei Liu
- Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Jiachang Chi
- Department of Interventional Oncology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Qing Sun
- Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Jiayuan Sun
- Respiratory Endoscopy Center and Respiratory Intervention Center, Shanghai Chest Hospital, Shanghai, China
| | - Xichao Sun
- Department of Pathology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Nuo Yang
- Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
| | - Juwei Mu
- Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
| | - Yuliang Li
- Department of Interventional Medicine, The Second Hospital Affiliated to Shandong University, Jinan, China
| | - Chengli Li
- Department of Imaging, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Chunhai Li
- Department of Radiology, Qilu Hospital of Shandong University, Jinan, China
| | - Xiaoguang Li
- Minimally Invasive Treatment Center, Beijing Hospital, Beijing, China
| | - Kang'an Li
- Department of Radiology, Shanghai General Hospital, Shanghai, China
| | - Po Yang
- Department of Interventional Vascular Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Xia Yang
- Department of Oncology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Fan Yang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
| | - Wuwei Yang
- Department of Oncology, The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Yueyong Xiao
- Department of Diagnostic Radiology, Chinese PLA General Hospital, Beijing, China
| | - Chao Zhang
- Department of Oncology, Affiliated Qujing Hospital of Kunming Medical University, Qujing, China
| | - Kaixian Zhang
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, China
| | - Lanjun Zhang
- Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Chunfang Zhang
- Department of Thoracic Surgery, Xiangya Hospital of Central South University, Changsha, China
| | - Linyou Zhang
- Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Yi Zhang
- Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Shilin Chen
- Department for Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing, China
| | - Jun Chen
- Department of Thoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China
| | - Kezhong Chen
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
| | - Weisheng Chen
- Department of Thoracic Surgery, Cancer Hospital Affiliated to Fujian Medical University, Fuzhou, China
| | - Liang Chen
- Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, Nanjing, China
| | - Haiquan Chen
- Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Jiang Fan
- Department of Thoracic Surgery, Shanghai General Hospital, Shanghai, China
| | - Zhengyu Lin
- Department of Intervention, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
| | - Dianjie Lin
- Department of Respiratory and Critical Care, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Lei Xian
- Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China
| | - Zhiqiang Meng
- Minimally Invasive Cancer Treatment Center, Fudan University Shanghai Cancer Hospital, Shanghai, China
| | - Xiaojing Zhao
- Department of Thoracic Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Jian Hu
- Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Hongtao Hu
- Department of Minimally Invasive Interventional Therapy, Henan Cancer Hospital, Zhengzhou, China
| | - Chen Liu
- Department of Interventional Therapy, Beijing Cancer Hospital, Beijing, China
| | - Cheng Liu
- Department of Imaging, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Wenzhao Zhong
- Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangzhou, China
| | - Xinshuang Yu
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Gening Jiang
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China
| | - Wenjie Jiao
- Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
| | - Weirong Yao
- Department of Radiology, Jiangxi Provincial People's Hospital, Nanchang, China
| | - Feng Yao
- Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China
| | - Chundong Gu
- Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Dong Xu
- Department of Ultrasound Medicine, Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China
| | - Quan Xu
- Department of Thoracic Surgery, Jiangxi Provincial People's Hospital, Nanchang, China
| | - Dongjin Ling
- Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Zhe Tang
- Department of Hepatobiliary and Pancreatic Surgery, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Yong Huang
- Department of Imaging, Cancer Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Guanghui Huang
- Department of Oncology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Zhongmin Peng
- Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Liang Dong
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
| | - Lei Jiang
- Department of Radiology, Huadong Sanatorium, Wuxi, China
| | - Junhong Jiang
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
| | - Zhaoping Cheng
- Nuclear Medicine-PET Center, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
| | - Zhigang Cheng
- Interventional Ultrasound, The First Medical Center, Chinese PLA General Hospital, Beijing, China
| | - Qingshi Zeng
- Department of Imaging, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
| | - Yong Jin
- Department of Interventional Therapy, The Second Affiliated Hospital of Soochow University, Suzhou, China
| | - Guangyan Lei
- Department of Thoracic Surgery, Shaanxi Provincial Cancer Hospital, Xi'an, China
| | - Yongde Liao
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Qunyou Tan
- Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, China
| | - Bo Zhai
- Department of Interventional Oncology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Hailiang Li
- Department of Minimally Invasive Interventional Therapy, Henan Cancer Hospital, Zhengzhou, China
| |
Collapse
|
4
|
Hu Y, Xue G, Liang X, Li Z, Wang N, Cao P, Wang G, Zhang H, Zheng X, Wang A, Zhao W, Han C, Wei Z, Ye X. Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study. Int J Hyperthermia 2024; 41:2307479. [PMID: 38314666 DOI: 10.1080/02656736.2024.2307479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Accepted: 01/15/2024] [Indexed: 02/06/2024] Open
Abstract
PURPOSE This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications. METHODS Between May 2020 and April 2022, 71 patients with 71 RML pulmonary nodules underwent 71 MWA sessions. To comparison, 142 patients with 142 pulmonary nodules in non-RML were selected using propensity score matching. The technical success, technique efficacy, complications, and associated factors were analyzed. The duration of the procedure and post-ablation hospital stay were also recorded. RESULTS Technical success was achieved in 100% of all patients. There were no significant differences in technique efficacy rates between the RML and non-RML groups (97.2% vs. 95.1%, p = 0.721). However, both major (47.9% vs. 19.7%, p < 0.001) and minor (26.8% vs. 11.3%, p = 0.004) pneumothorax were more common in the RML group than non-RML group. MWA for RML pulmonary nodules was identified as an independent risk factor for pneumothorax (p < 0.001). The duration of procedures (51.7 min vs. 35.3 min, p < 0.001) and post-ablation hospital stays (4.7 days vs. 2.8 days, p < 0.001) were longer in the RML group than non-RML group. CONCLUSIONS CT-guided MWA for RML pulmonary nodules showed comparable efficacy compared with other lobes, but posed a higher risk of pneumothorax complications, necessitating longer MWA procedure times and extended hospital stays.
Collapse
Affiliation(s)
- Yanting Hu
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Guoliang Xue
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Xinyu Liang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
- Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
| | - Zhichao Li
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Nan Wang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Pikun Cao
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Gang Wang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Haitao Zhang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Xiaohuan Zheng
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Aiguang Wang
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Wenhua Zhao
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Cuiping Han
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Zhigang Wei
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| | - Xin Ye
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
| |
Collapse
|